Your search returned 17 results.

Results
	1.	Thioredoxin signaling as a target for cancer therapy. [electronic resource] by Powis, Garth Kirkpatrick, D Lynn Producer: 20071108 In: Current opinion in pharmacology vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling. [electronic resource] by Kirkpatrick, D Lynn Powis, Garth Producer: 20170810 In: Antioxidants & redox signaling vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Practicalities of drugging the phosphatidylinositol-3-kinase/Akt cell survival signaling pathway. [electronic resource] by Powis, Garth Ihle, Nathan Kirkpatrick, D Lynn Producer: 20060726 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Solubility, ionization, and partitioning behavior of unsymmetrical disulfide compounds: alkyl 2-imidazolyl disulfides. [electronic resource] by Hashash, Ahmad Kirkpatrick, D Lynn Lazo, John S Block, Lawrence H Producer: 20021211 In: Journal of pharmaceutical sciences vol. 91 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase. [electronic resource] by Powis, Garth Wipf, Peter Lynch, Stephen M Birmingham, Anne Kirkpatrick, D Lynn Producer: 20060526 In: Molecular cancer therapeutics vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Normal-phase and stability-indicating reversed-phase high-performance liquid chromatographic methods for the determination of the novel antitumor agent: 1-methylpropyl-2-imidazolyldisulfide. [electronic resource] by Hashash, Ahmad Kirkpatrick, D Lynn Egorin, Merrill J Block, Lawrence H Lazo, John S Producer: 20020829 In: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences vol. 768 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Carbon Nanotubes: Solution for the Therapeutic Delivery of siRNA? [electronic resource] by Kirkpatrick, D Lynn Weiss, Michelle Naumov, Anton Bartholomeusz, Geoffrey Weisman, R Bruce Gliko, Olga Publication details: Materials (Basel, Switzerland) Feb 2012 In: Materials (Basel, Switzerland) vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	In vitro and in vivo assessment of the abuse potential of PF614, a novel BIO-MD™ prodrug of oxycodone. [electronic resource] by Kirkpatrick, D Lynn Schmidt, William K Morales, Ricardo Cremin, John Seroogy, Julie Husfeld, Craig Jenkins, Thomas Producer: 20180524 In: Journal of opioid management vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation. [electronic resource] by Welsh, Sarah J Williams, Ryan R Birmingham, Anne Newman, David J Kirkpatrick, D Lynn Powis, Garth Producer: 20031211 In: Molecular cancer therapeutics vol. 2 Availability: No items available. Save to lists Add to cart (remove)
	10.	Multi-Drug/Gene NASH Therapy Delivery and Selective Hyperspectral NIR Imaging Using Chirality-Sorted Single-Walled Carbon Nanotubes. [electronic resource] by Hasan, Md Tanvir Campbell, Elizabeth Sizova, Olga Lyle, Veronica Akkaraju, Giridhar Kirkpatrick, D Lynn Naumov, Anton V Publication details: Cancers Aug 2019 In: Cancers vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha. [electronic resource] by Koh, Mei Y Spivak-Kroizman, Taly Venturini, Sara Welsh, Sarah Williams, Ryan R Kirkpatrick, D Lynn Powis, Garth Producer: 20080403 In: Molecular cancer therapeutics vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma. [electronic resource] by Baker, Amanda F Dragovich, Tomislav Tate, Wendy R Ramanathan, Ramesh K Roe, Denise Hsu, Chiu-Hsieh Kirkpatrick, D Lynn Powis, Garth Producer: 20060524 In: The Journal of laboratory and clinical medicine vol. 147 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance. [electronic resource] by Ihle, Nathan T Lemos, Robert Wipf, Peter Yacoub, Adly Mitchell, Clint Siwak, Doris Mills, Gordon B Dent, Paul Kirkpatrick, D Lynn Powis, Garth Producer: 20090130 In: Cancer research vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non-small cell lung cancer xenografts. [electronic resource] by Ihle, Nathan T Paine-Murrieta, Gillian Berggren, Margareta I Baker, Amanda Tate, Wendy R Wipf, Peter Abraham, Robert T Kirkpatrick, D Lynn Powis, Garth Producer: 20060104 In: Molecular cancer therapeutics vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma. [electronic resource] by Koul, Dimpy Shen, Ruijun Kim, Yong-Wan Kondo, Yasuko Lu, Yiling Bankson, Jim Ronen, Sabrina M Kirkpatrick, D Lynn Powis, Garth Yung, W K Alfred Producer: 20110222 In: Neuro-oncology vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors. [electronic resource] by Ramanathan, Ramesh K Kirkpatrick, D Lynn Belani, Chandra P Friedland, David Green, Sylvan B Chow, H-H Sherry Cordova, Catherine A Stratton, Steven P Sharlow, Elizabeth R Baker, Amanda Dragovich, Tomislav Producer: 20070621 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor. [electronic resource] by Meuillet, Emmanuelle J Zuohe, Song Lemos, Robert Ihle, Nathan Kingston, John Watkins, Ryan Moses, Sylvestor A Zhang, Shuxing Du-Cuny, Lei Herbst, Roy Jacoby, Jörg J Zhou, Li Li Ahad, Ali M Mash, Eugene A Kirkpatrick, D Lynn Powis, Garth Producer: 20100618 In: Molecular cancer therapeutics vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)